Clinical Trial Update: A Study of Oxytocin for the Treatment of Social Impairment in Individuals With High Functioning Autism Spectrum Disorder [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating oxytocin for social impairment in individuals with high-functioning autism spectrum disorder has completed, with trial resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder
• Pervasive Developmental Disorder

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Autism Spectrum Disorder, Pervasive Developmental Disorder | Phase 3 | Status: COMPLETED | Results posted: 2023-08-16